Detection of subclinical atherosclerosis in familial hypercholesterolemia using non-invasive imaging modalities

Atherosclerosis

Volumn 222, Issue 2, 2012, Pages 468-472

  Caballero, Paloma ^a   Alonso, Rodrigo ^b   Rosado, Paloma ^a   Mata, Nelva ^c   Fernández Friera, Leticia ^d   Jiménez Borreguero, Luis Jesús ^e   Badimon, Lina ^f   Mata, Pedro ^b  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b 28400 Madrid   (Spain)

^c Madrid Regional Authority   (Spain)

^d CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^e INSTITUTO DE INVESTIGACIÓN SANITARIA DEL HOSPITAL CLÍNICO SAN CARLOS IDISSC   (Spain)

^f HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Aorta; Atherosclerosis; Familial Hypercholesterolemia; MRI; Ultrasound

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AORTA WALL; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; B SCAN; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATIONAL STUDY; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILY HISTORY; FEMALE; HUMAN; HYPERTENSION; MALE; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SUBCLINICAL ATHEROSCLEROSIS; THORACIC AORTA; TRIACYLGLYCEROL BLOOD LEVEL; XANTHOMA;

ADULT; AGE OF ONSET; AORTA, THORACIC; AORTIC DISEASES; ASYMPTOMATIC DISEASES; ATHEROSCLEROSIS; CAROTID ARTERY DISEASES; CAROTID ARTERY, COMMON; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; HYPOLIPIDEMIC AGENTS; LINEAR MODELS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLAQUE, ATHEROSCLEROTIC; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; SPAIN;

EID: 84861348372     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.02.043     Document Type: Article

References (21)

1. Goldstein J.L., Hobbs H.H., Brown M.S. Familial hypercholesterolemia. The metabolic and molecular basis of inherited disease 2001, vol. II:2863-2913. McGraw Hill, New York.
2. Wierzbicki A.S., Humphries S.E., Minhas R. Familial hypercholesterolemia: summary of NICE guidance. BMJ 2008, 337:a1095.
3. Neil A., Cooper J., Betteridge J., et al. Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study. Eur Heart J 2008, 29:2625-2633.
4. Versmissen J., Oosterveer D.M., Yazdanpanah M., et al. Efficacy of statins in familial hypercholesterolaemia: a long term cohort study. BMJ 2008, 337:a2423.
5. Mata N., Alonso R., Badimon L., et al. Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART). Lipids Health Dis 2011, 10:94.
6. Civeira F. International panel on management of familial hypercholesterolemia. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. Atherosclerosis 2004, 173:55-68.
7. Sharma K., Blaha M.J., Blumenthal R.S., Musunuru K. Clinical and research applications of carotid intima-media thickness. Am J Cardiol 2009, 103:1316-1320.
8. Corti R., Fuster V. Imaging of atherosclerosis: magnetic resonance imaging. Eur Heart J 2011, 32:1709-1719.
9. Schmitz S., O'Regan D., Fitzpatric J., et al. Quantitative 3T MR imaging of the descending thoracic aorta: patients with familial hypercholesterolemia have an increased aortic plaque burden despite long-term lipid-lowering therapy. J Vasc Interv Radiol 2008, 19:1403-1408.
10. Soljanlahti S., Autti T., Vuorio A.F., Keto P., Turtola H., Lauerma K. Aorta of young and middle-aged heterozygous familial hypercholesterolemia patients shows no functional or morphological impairment assessed by MRI. Vasc Health Risk Manage 2008, 4:923-929.
11. Alonso R., Mata N., Castillo S., et al. Cardiovascular disease in familial hypercholesterolaemia: influence of low-density lipoprotein receptor mutation type and classic risk factors. Atherosclerosis 2008, 200:315-321.
12. Yonemura A., Momiyama Y., Fayad Z.A., et al. Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques detected by noninvasive magnetic resonance imaging. J Am Coll Cardiol 2005, 45:733-742.
13. Jaffer F.A., O'Donnell C.J., Larson M.G., et al. Age and sex distribution of subclinical aortic atherosclerosis: a magnetic resonance imaging examination of the Framingham heart study. Arterioscler Thromb Vasc Biol 2002, 22:849-854.
14. Fernández-Ortiz A., Badimon J.J., Falk E., et al. Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J Am Coll Cardiol 1994, 23:1562-1569.
15. Finn A., Kolodgie F., Virmani R. Correlation between carotid intimal/medial thickness and atherosclerosis: a point of view from pathology. Arterioscler Thromb Vasc Biol 2010, 30:177-181.
16. Momiyama Y., Fayad Z.A. Aortic plaque imaging and monitoring atherosclerotic plaque interventions. Top Magn Reson Imaging 2007, 18:349-355.
17. Martinez L.R.C., Miname M.H., Bortolotto L.A., et al. No correlation and low agreement of imaging and inflammatory atherosclerosis' markers in familial hypercholesterolemia. Atherosclerosis 2008, 200:83-88.
18. Miname M.H., Ribeiro M.S., Parga Filho J.P., et al. Evaluation of subclinical atherosclerosis by computed tomography coronary angiography and its association with risk factors in familial hypercholesterolemia. Atherosclerosis 2010, 213:486-491.
19. Neefjes L.A., Ten Kate G.J., Rossi A., et al. CT coronary plaque burden in asymptomatic patients with familial hypercholesterolemia. Heart 2011, 97:1151-1157.
20. Taniguchi H., Momiyama Y., Fayad Z.A., et al. In vivo magnetic resonance evaluation of associations between aortic atherosclerosis and both risk factors and coronary artery disease in patients referred for coronary angiography. Am Heart J 2004, 148:137-143.
21. Mani V., Muntner P., Gidding S., et al. Cardiovascular magnetic resonance parameters of atherosclerotic plaque burden improves discrimination of prior major adverse cardiovascular events. J Cardiovasc Magn Reson 2009, 11:10.